Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Microhemmorhage

Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   



Living with dementia

alzheimer's imaging agents1 - apolipoprotein e2 - beta-amyloid peptides1 - solanezumab1 - transient ischaemic attack1 - neurotransmitter1 - thiamine deficiency4 - journal of clinical nursing1 - prion disease1 - alzheimer disease6 - alzheimer's warning signs1 - preventing alzheimer's1 - haloperidol2 - pfizer1 - executive function1 - amyloid-β1 - symptoms of parkinson's disease1 - mild dementia2 - dementia alliance1 - alzheimer's changes2 - early alzheimer's disease1 - sleepiness1 - pre-dementia2 - memory7 - alzheimer's disease symptoms1 - signs of parkinson's1 - amyloidosis1 - imbecility1 - foolishness1 - korsakoff psychosis11 -